Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dai Shi

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Cell|October 16, 2025
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosisChuan Qin, Ming-Hao Dong, Luo-Qi Zhou, et al.
Molecular Neurodegeneration|July 31, 2024
Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's diseaseTengfei Guo, Anqi Li, Pan Sun, et al.
Journal of the American Chemical Society|June 19, 2003
Discovery of a potent, non-peptide bradykinin B1 receptor antagonistDai-Shi Su, M Kristine Markowitz, Robert M DiPardo, et al.
Molecular Neurodegeneration|January 14, 2026
Plasma platelet-derived growth factor receptor-β decrease correlates with blood-brain barrier damage in Alzheimer's diseaseJieyin Li, Anqi Li, Chenghui Ye, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2007
Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanesDai-Shi Su, John L Lim, M Kristine Markowitz, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 29, 2017
A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1Dean E McNulty, William G Bonnette, Hongwei Qi, et al.
Molecular Pharmacology|October 7, 2015
Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1α Endoribonuclease ActivityNestor O Concha, Angela Smallwood, William Bonnette, et al.
Stroke and Vascular Neurology|November 23, 2022
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 2018Dai-Shi Tian, Chen-Chen Liu, Chao-Long Wang, et al.
Journal of Medicinal Chemistry|June 17, 2008
2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonistsDai-Shi Su, John L Lim, Elizabeth Tinney, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2026
k5-mediated microglial ferroptosis drives ischemic white matter damage via the Nfatc4-Clptm1l axisYun-Hui Chu, Lu-Yang Zhang, Jia-Yi He, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Cell|October 16, 2025
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosisChuan Qin, Ming-Hao Dong, Luo-Qi Zhou, et al.
Molecular Neurodegeneration|July 31, 2024
Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's diseaseTengfei Guo, Anqi Li, Pan Sun, et al.
Journal of the American Chemical Society|June 19, 2003
Discovery of a potent, non-peptide bradykinin B1 receptor antagonistDai-Shi Su, M Kristine Markowitz, Robert M DiPardo, et al.
Molecular Neurodegeneration|January 14, 2026
Plasma platelet-derived growth factor receptor-β decrease correlates with blood-brain barrier damage in Alzheimer's diseaseJieyin Li, Anqi Li, Chenghui Ye, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2007
Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanesDai-Shi Su, John L Lim, M Kristine Markowitz, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 29, 2017
A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1Dean E McNulty, William G Bonnette, Hongwei Qi, et al.
Molecular Pharmacology|October 7, 2015
Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1α Endoribonuclease ActivityNestor O Concha, Angela Smallwood, William Bonnette, et al.
Stroke and Vascular Neurology|November 23, 2022
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 2018Dai-Shi Tian, Chen-Chen Liu, Chao-Long Wang, et al.
Journal of Medicinal Chemistry|June 17, 2008
2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonistsDai-Shi Su, John L Lim, Elizabeth Tinney, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2026
k5-mediated microglial ferroptosis drives ischemic white matter damage via the Nfatc4-Clptm1l axisYun-Hui Chu, Lu-Yang Zhang, Jia-Yi He, et al.
Pageof 23